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Abstract 
Zhu, Y. 2007. Early inflammatory response in periparturient sows to experimentally 
induced Escherichia coli mastitis with special reference to cytokine responses. Doctoral 
dissertation.  
ISSN 1652-6880, ISBN 978-91-576-7397-8 
 
The overall objective of the present work was to monitor the induction of some key factors 
involved in the early inflammatory response in the mammary gland of periparturient sows 
to experimentally induced Escherichia coli (E. coli) mastitis. We wanted to gain a better 
understanding of why some sows develop clinical signs of mastitis, while others remain 
clinically healthy.  
Concentrations of the proinflammatory cytokines interleukin (IL)-6 and tumour necrosis 
factor-alpha (TNF-α), and the acute-phase protein (APP) serum amyloid A (SAA) in blood 
increased in sows following intramammary E. coli inoculation as measured by enzyme-
linked immunosorbent assay (ELISA). Furthermore, concentrations of IL-6 and TNF-α in 
blood were higher in sows that developed clinical signs of mastitis than in sows that 
remained clinically healthy after inoculation. Notably, immunohistochemistry (IHC) 
analysis of biopsy specimen revealed that some baseline production of cytokines took place 
in normal mammary glands of pregnant sows, and that sows that developed clinical signs of 
mastitis had significantly lower baseline production of IL-1β than did sows that remained 
clinically healthy. Twenty-four hours after inoculation, there was an increase in the 
production of IL-1β, IL-6, IL-8 and TNF-α in the inoculated mammary glands of sows that 
developed clinical signs of mastitis. By contrast, sows that remained clinically healthy did 
not show increased production of IL-1β, IL-6 and TNF-α in the inoculated mammary 
glands. However, at the mRNA level there was an increase in the expression of IL-1β and 
TNF-α also in these sows. The anti-inflammatory cytokine IL-10 mRNA expression 
increased in the inoculated mammary glands 24 hours after inoculation, and it was higher in 
the inoculated mammary glands of sows that developed clinical signs of mastitis compared 
with sows that remained clinically healthy, while the expression of another anti-
inflammatory cytokine, transforming growth factor-beta 1 (TGF-β1) mRNA was unaltered, 
as was mRNA expression for the IL-1 receptor type I (IL-1R1).  
In addition, the pattern-recognition receptor (PRR) Toll-like receptor 2 (TLR2) mRNA 
expression increased in the inoculated as well as the non-inoculated mammary glands of 
sows that developed clinical signs of mastitis and of sows that remained clinically healthy. 
However, TLR2 mRNA expression was higher in the inoculated mammary glands than in 
the non-inoculated mammary glands of sows that remained clinically healthy.  
The findings of the present study suggest that IL-6 and/or TNF-α in blood could be used 
as markers for identification of periparturient sows with coliform mastitis, and that 
development of clinical symptoms of coliform mastitis is associated with the degree of local 
production of regulatory cytokines in response to intramammary E. coli inoculation.  
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Abbreviations 
A P C         a n t i g e n - p r e s e n t i n g   c e l l        
APP       acute-phase  protein 
cDNA      complementary  deoxyribonucleic  acid 
CFU        colony-forming  unit 
DAB        3,  3’-diaminobenzidine  tetrahydrochloride 
DC         dendritic  cell 
DNaseI       deoxyribonuclease  I 
E          amplification  efficiency 
E. coli      Escherichia coli 
ELISA       enzyme-linked  immunosorbent  assay   
GAPDH     glyceraldehyde  3-phosphate  dehydrogenase 
gDNA      genomic  deoxyribonucleic  acid 
Hp         haptoglobin 
HPA        hypothalamic-pituitary-adrenal 
HPRT      hypoxanthine phosphoribosyl-transferase 
IHC       immunohistochemistry 
I L         i n t e r l e u k i n  
IL-1R1       type  I  IL-1  receptor 
IL-1RAcP      IL-1  receptor  accessory  protein 
LBP       LPS-binding  protein 
LPS       lipopolysaccharide 
LTA        lipoteichoic  acid 
MIP2        macrophage  inflammatory  protein-2 
mRNA       messenger  RNA 
NF-κB       nuclear  factor-κB 
PAMP      pathogen-associated  molecular  pattern 
PBMC       peripheral  blood  mononuclear  cell 
PCR       polymerase  chain  reaction 
PG         prostaglandin   
PGN        peptidoglycan 
PHS       periparturient  hypogalactia  syndrome 
PRR       pattern-recognition  receptor 
qRT-PCR      quantitative  real-time  RT-PCR 
RNA        ribonucleic  acid 
RT-PCR     reverse  transcriptase-PCR 
S A A         s e r u m   a m y l o i d   A  
SCC       somatic  cell  count 
TGF-β1       transforming  growth  factor-beta  1   
TH         T   h e l p e r  
TH1         T  helper  type  1 
TIR         Toll/IL-1R   
TLR       Toll-like  receptor 
TNF-α       tumour  necrosis  factor-alpha 
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Introduction  
Rationale 
Mastitis affects sows in all regions of the world and plays a major role in the 
periparturient hypogalactia syndrome (PHS) (Bäckström et al., 1984; Hermansson 
et al., 1978; Martineau, Smith & Doizé, 1992; Ringarp, 1960). Although PHS in 
the sow has been recognized for years, effective prophylactic and therapeutic 
management of the problem has frequently remained an elusive goal for the 
practitioner. Gram-negative pathogens, e.g. Escherichia coli (E. coli), Klebsiella 
pneumoniae (K. pneumoniae) and various species of Enterobacter constitute the 
most common pathogens implicated in coliform mastitis (Bertschinger, 1999; Ross 
et al., 1981). Most coliform mastitis in sows is caused by E. coli and occurs within 
the first few days postpartum (Hermansson et al., 1978; Ringarp, 1960). Coliform 
mastitis is acute in nature and rarely becomes chronic (Persson, Pedersen Mörner 
& Kuhl, 1996b; Ringarp, 1960; Smith & Hogan, 1993). It can be subclinical or 
exhibit a wide range of symptoms, from mild to severe with general clinical signs, 
such as fever, anorexia, lethargy, swelling of the mammary glands, milk with clots 
and an abnormal appearance, and losses in milk production (Persson, Pedersen 
Mörner & Kuhl, 1996b; Ringarp, 1960; Ross et al., 1975; Smith & Wagner, 
1984). It is well known that bacterial, environmental, management, genetic and 
physiological factors influence mastitis susceptibility in the sow as well as in the 
cow (Persson et al., 1989; Sordillo & Streicher, 2002; Waller, 2000), but the 
reason why certain sows develop clinical signs of mastitis when challenged with 
environmental E. coli, while others remain clinically healthy, is still elusive.  
 
An inflammatory response to microbial invasion or injury is a part of the early 
defence mechanisms. Such a reaction has to be activated as soon as possible to 
terminate the spread of infection, even at the cost of further tissue damage. The 
inflammatory response may cause more damage than the microbe itself and must 
therefore be fine-tuned and regulated precisely. Therefore, excessive responses 
may cause morbidity and mortality, while insufficient responses in 
immunodeficient individuals may allow an infection to become established 
(Cohen, 2002; Nathan, 2002; Tracey, 2002). During the early stages of 
intramammary infections, macrophages together with epithelial cells initiate the 
inflammatory response to eliminate invading bacteria; however, an insufficient as 
well as excessive inflammatory response may lead to mastitis (Oviedo-Boyso et 
al., 2007; Rainard & Riollet, 2006; Sordillo, Shafer-Weaver & DeRosa, 1997). 
Hence, studies on early inflammatory responses in periparturient sows to 
experimentally induced E. coli mastitis may improve our understanding of how 
environmental bacterial components trigger manifestations of acute infectious 
disease in the host. 
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Coliform mastitis 
Escherichia coli is an organism that is most often identified in either milk samples 
or infected mammary glands, and that is associated with various forms of 
subclinical and clinical mastitis in sows (Armstrong, Hooper & Martin, 1968; 
Persson, Pedersen Mörner & Kuhl, 1996b; Ringarp, 1960; Ross et al., 1981). 
However, coliform mastitis in sows appears to be non-contagious. An early 
Swedish study reported an average PHS incidence in sows of 12.8% (signs of 
mastitis were found in 45−52% of agalactic sows) (Hermansson et al., 1978). 
Field studies from the United States (Bäckström et al., 1984) and Denmark 
(Svendsen et al., 1975) on mastitis in sows showed an incidence of mastitis of 
6.9% and 9.5%, respectively. A previous study has shown that the mortality rate of 
piglets nursing multiparous sows with mastitis was 56%, while that of piglets 
nursing healthy sows was only 17% (Bäckström et al., 1984). Notably, the 
subclinical form of mastitis is more difficult to diagnose; however, piglets 
suckling on glands of sows with mastitis have lower mean weights owing to 
insufficient milk intake (Persson, Pedersen Mörner & Kuhl, 1996b; Ross et al., 
1975; Smith & Wagner, 1984).  
 
Studies in cattle have shown that indicators of inflammation can be used in the 
diagnosis of mastitis (Pyörälä, 2003). Today, the most commonly used indicator of 
bovine mastitis is somatic cell count (SCC), which reflects the disease-combating 
response of the animal to the pathogen. Due to the normally higher somatic cell 
content of sow’s milk, with an SCC of between 1 and 4 million cells per millilitre 
in healthy sows (Hurley & Grieve, 1988; Magnusson, Rodríguez-Martínez & 
Einarsson, 1991; Persson, Pedersen Mörner & Kuhl, 1996a; Schollenberger et al., 
1986), tests developed for use in the cow cannot be recommended. Acute-phase 
proteins (APPs) such as serum amyloid A (SAA) and haptoglobin (Hp) are 
potential candidates for bovine mastitis monitoring (Petersen, Nielsen & 
Heegaard, 2004). A recent review has proposed that the subtle and sensitive 
changes in the cytokine network in normal and mastitic bovine mammary glands 
may encourage the use of cytokines in the diagnosis and prognosis of udder health 
(Alluwaimi, 2004), but their diagnostic value in porcine mastitis and PHS has not 
yet been confirmed. 
 
General aspects of defence mechanisms in the mammary gland 
The mammary gland is protected by the physical barrier of the teat streak canals 
and a variety of immune defence mechanisms. The teat streak canal is tightly 
closed by longitudinal folds that come from the teat cistern to the teat canal. 
Together with the teat skin and the milk flow, the teat canal constitutes the first 
line of defence against intramammary infections.  
 
The immune system can be divided into two subsystems: innate immunity and 
adaptive immunity. The bovine mammary gland defence mechanisms, including 
physical, soluble and cellular factors, have been previously reviewed (Burton & 
Erskine, 2003; Burvenich et al., 2003; Kehrli & Harp, 2001; Sordillo, Shafer-
Weaver & DeRosa, 1997; Sordillo & Streicher, 2002). In brief, the mammary   11 
gland contains chemical substances that are microbicidal or inhibit microbial 
growth, e.g. lysozyme and the enzyme lactoperoxidase, the antimicrobial proteins 
lactoferrin and transferrin, and the antimicrobial peptides defensins (Rainard & 
Riollet, 2006). In addition, the complement system is a group of plasma proteins, 
with effector functions that include recruitment of phagocytes, and opsonization 
and killing of pathogens (Rainard, 2003).  
 
Phagocytes such as macrophages and neutrophils can recognize, ingest and 
eliminate the invading micro-organisms (Burvenich et al., 1999; Paape et al., 
2002). Proinflammatory cytokines are known to be important in eliciting the 
acute-phase response and allowing an accumulation of leukocytes at the site of 
infection (Riollet, Rainard & Poutrel, 2000a). Taken together, the innate immune 
response makes an important first line of defence but also has a crucial role in the 
activation of adaptive immunity.  
 
Inflammatory responses later in an infection also involve lymphocytes. All 
lymphocyte responses to antigen require not only the signal that results from 
antigen binding to their receptors, but also, a second signal, which is delivered by 
another cell. T cells need antigen-receptor engagement plus signals from antigen-
presenting cells (APCs). B cells need antigen-receptor engagement plus signals 
from activated T cells. The antibodies, which bind pathogens or their products in 
the extracellular space of the body, can prevent the antigen from exerting its 
actions and amplify the innate immune response (Kehrli & Harp, 2001; Sordillo, 
Shafer-Weaver & DeRosa, 1997). 
 
With regards to mammary gland defence mechanisms in the sow, an increase in 
the number of granulocytes, found in blood at parturition, has been reported 
(Magnusson & Fossum, 1990; Österlundh, Holst & Magnusson, 1998). Likewise, 
a higher number of granulocytes has been seen in mammary secretions collected at 
parturition compared with samples collected on days 2 or 3 (Österlundh, Holst & 
Magnusson, 1998) or 7 postpartum (Magnusson & Greko, 1998), and the 
phagocytic capacity of granulocytes in blood as well as in mammary secretions did 
not vary around parturition (Magnusson & Greko, 1998; Österlundh, Holst & 
Magnusson, 1998). By contrast, a later study showed lower phagocytic capacity of 
granulocytes in colostrum compared with that in milk collected from 12 to 13 days 
postpartum (Österlundh, Holst & Magnusson, 2001). Moreover, before 
intramammary E. coli inoculation, no impaired function of granulocytes was found 
in sows that developed clinical signs of mastitis (Österlundh et al., 2002). On the 
other hand, after inoculation, the proportion of CD4+ and CD8+ lymphocytes was 
higher in the mammary glands of sows that developed clinical signs of mastitis 
than in those that remained clinically healthy in the same experiment (Löving & 
Magnusson, 2002).  
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The early inflammatory response 
Inflammation is a complex set of interactions among soluble factors and cells, 
which can arise in any tissue in response to microbial invasion or injury. 
Inflammatory responses are operationally characterized by pain, redness, heat, and 
swelling at the site of infection. An acute inflammatory response results in 
increased local blood flow, increased vascular permeability, and an accumulation 
of leukocytes and certain soluble factors in the tissue. Initiation of the 
inflammatory response occurs primarily through activated macrophages, mast 
cells, together with epithelial cells at the site of infection or injury. On activation, 
macrophages (Cohen, 2002) and mast cells (Benoist & Mathis, 2002) as well as 
epithelial cells (Svanborg, Godaly & Hedlund, 1999) rapidly release cytokines and 
other inflammatory mediators such as histamine, leukotrienes, prostaglandins, 
nitric oxide and toxic oxygen radicals, which promote further inflammation and 
tissue injury. Following the induction of the inflammatory response, the liver and 
other tissues undergo dramatic upregulation and synthesis of a variety of APPs 
which can mediate or inhibit inflammatory processes, function as transport 
proteins and participate in tissue repair (Baumann & Gauldie, 1994; Tilg, 
Dinarello & Mier, 1997).  
  
As the inflammation progresses, leukocytes, lymphocytes and other cells are 
activated and recruited to the inflamed site by a signalling network involving a 
great number of cytokines including growth factors and chemokines (Conti et al., 
2004; Coussens & Werb, 2002; Dinarello, 2004; Nathan, 2002). Cytokines serve 
in both autocrine and paracrine manners, affecting the behaviour of the cells at the 
site of inflammation. Some cytokines can also act as messengers (Havell & 
Sehgal, 1991) between the local site of infection or injury and other sites in the 
body, e.g. inducing hepatocytes to synthesize APPs (Baumann & Gauldie, 1994; 
Steel & Whitehead, 1994; Tilg, Dinarello & Mier, 1997). Another way in which 
pathogen recognition rapidly triggers an inflammatory response is through 
activation of the complement cascade (Janeway et al., 2001).  
 
The inflammatory response is usually a healing response, since it is a reaction 
designed to terminate the spread of infection. However, under certain 
circumstances, many of the components of the inflammatory response can cause 
cell and tissue damage, microvascular thrombosis, fever, systemic capillary 
leakage syndrome, and hence multiple organ failure, sepsis and even death 
(Cohen, 2002). To avoid detrimental inflammatory reactions, a balance between 
activation and inhibition is needed throughout the immune response. Therefore, 
anti-inflammatory mediators are also released that limit the acute inflammatory 
response and prevent the spread of inflammatory mediators into the bloodstream 
(Tracey, 2002).  
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The Toll-like/interleukin-1 receptor superfamily 
The initial recognition of infectious agents or parts of the microbes, as they enter 
the body, is largely based on pattern-recognition receptors (PRRs) that are present 
on or in various cells in the body (Aderem & Ulevitch, 2000; Hallman, Rämet & 
Ezekowitz, 2001).  
 
Toll-like receptors (TLRs) constitute an ancient family of PRRs. In the murine 
system up to 13 TLRs have been identified (Akira, Uematsu & Takeuchi, 2006; 
Hallman, Rämet & Ezekowitz, 2001; Takeda, Kaisho & Akira, 2003). It seems 
that many inflammatory processes, both sterile and infectious, may depend on 
TLR signalling (Akira & Takeda, 2004; Beutler, 2004; Cohen, 2002). Signalling 
via TLRs may commonly lead to early activation of the transcription factor 
nuclear factor-κB (NF-κB) and the release of several proinflammatory mediators, 
including the proinflammatory cytokines interleukin (IL)-1β, IL-6, IL-8 and 
tumour necrosis factor-alpha (TNF-α) (Akira, Uematsu & Takeuchi, 2006; 
Pålsson-McDermott & O’Neill, 2004; Raetz & Whitfield, 2002). Toll-like 
receptors recognize pathogens at either the cell surface or on lysosome/endosome 
membranes (Akira, Uematsu & Takeuchi, 2006). The variability of bacterial 
ligands and their innate immune receptors is an important factor in determining the 
outcome of infectious disease (Miller, Ernst & Bader, 2005).  
 
Pattern-recognition receptors recognize the invading pathogens through 
identification of conserved components of these microbes. These microbial 
structures are termed “pathogen-associated molecular patterns (PAMPs)” and 
include various bacterial cell wall components, such as lipopolysaccharide (LPS), 
lipopeptides, peptidoglycan (PGN) and lipoteichoic acid (LTA) (Aderem & 
Ulevitch, 2000). In the case of Gram-negative bacteria, the recognition of LPS 
from Gram-negative bacteria is mediated by CD14, LPS-binding protein (LBP), 
MD-2 (Shimazu et al., 1999) and TLR4. This TLR, TLR4, is the main PRR for 
LPS from Gram-negative bacteria. Another TLR, TLR2, on the other hand, 
recognizes LTA from Gram-positive bacteria, peptidoglycan and bacterial 
lipoproteins abundant in the cell wall of Gram-positive and Gram-negative 
bacteria, and other bacterial products that are distinct from Gram-negative LPS 
(Brightbill et al., 1999; Grabig et al., 2006; Werts et al., 2001). One study reports 
when TLR4-/- knockout mice were challenged with LPS, and that they were 
unable to mount a cellular immune response, with no detectable change in TNF-α 
expression (Hoshino et al., 1999). In some human diseases, single gene defects 
that result in the failure of a particular innate immune receptor to be expressed 
cause general increased susceptibility to infection (Altare et al., 1998; Picard et 
al., 2003). As regards mastitis, a previous study has shown that both TLR2 and 
TLR4 mRNA expression increased in infected mammary glands of cows with 
mastitis caused by either Staphylococcus aureus ( S. aureus) or E. coli 
(Goldammer et al., 2004). 
  
The IL-1 receptor family includes type I IL-1 receptor (IL-1R1), IL-1R2, the IL-
1 receptor accessory protein (IL-1RAcP), IL-18R, IL-18RAcP, and the orphan 
receptor T1/ST2 (Subramaniam, Stansberg & Cunningham, 2004). Type I IL-1   14
receptor is expressed on endothelial, epithelial, epidermal dendritic cells, 
fibroblasts and T cells as an 80 kDa protein (Dinarello, 1996; Sims et al., 1988). 
Interleukin-1 exerts its biological actions by binding to specific receptors 
including IL-1R1 and IL-1R2 (Allan, Tyrrell & Rothwell, 2005; Liew, Liu & Xu, 
2005; Subramaniam, Stansberg & Cunningham, 2004).  
 
Based on the homologous cytosolic Toll/IL-1R (TIR) domain, the TLR/IL-1R 
superfamily includes TLRs and the IL-1 receptor family subgroups (Bowie & 
O’Neill, 2000; Dunne & O’Neill, 2003). Except for IL-1R2 and T1/ST2 (Liew, 
Liu & Xu, 2005), all members of this superfamily activate common signalling 
pathways, most notably leading to activation of NF-κB and stress-activated protein 
kinases (Dunne & O’Neill, 2003; Subramaniam, Stansberg & Cunningham, 2004).  
 
Cytokines  
Cytokines can be defined as a group of small, soluble proteins (-25 kDa) that at 
low concentrations are able to regulate the function of cells and tissues (Janeway 
et al., 2001). They are released by various cells in the body, usually in response to 
an activating stimulus, and mediate their effects through binding to specific 
receptors. In addition, to differentiate cytokines from classic hormones, cytokines 
can be produced by cells not organized in specific glandular organs. Using this 
very broad definition, cytokines would include interleukins, chemokines, 
interferons, colony- stimulating factors, peptide growth factors, tumour necrosis 
factors (Nathan & Sporn, 1991), and other proteins (Phillips et al., 2005) that are 
often not perceived as immune regulators but interact with the immune cells, 
including activins and inhibins. Cytokines can act in an autocrine manner that 
affects the behaviour of the cell that releases cytokines, or in a paracrine manner 
that affects the behaviour of adjacent cells. Most cytokines act at near distances, 
but some cytokines can act in an endocrine manner that affects the behaviour of 
distant cells. The latter ability depends both on their ability to enter the circulation 
and on their half-life (Janeway et al., 2001).   
 
Monocytes/macrophages, neutrophils, mast cells, dendritic cells (DCs), B cells, 
various types of T cells, and even fibroblasts and endothelial and epithelial cells 
are potently triggered to release cytokines through the innate immune system using 
PRRs during the inflammatory process (Aderem & Underhill, 1999; Akira & 
Takeda, 2004; Bannerman & Goldblum, 2003; Benoist & Mathis, 2002; Svanborg, 
Godaly & Hedlund, 1999). Alternatively, processing of antigens as they are taken 
up by APCs, metabolized, and presented to T helper (TH) lymphocytes provides 
one pathway for this class of cytokine production (Borish & Steinke, 2003; 
Steinke & Borish, 2006). A diverse range of genetic and external factors can affect 
cytokine production and activity at various stages, including transcription, 
translation, cleavage and cellular release, or at the level of interaction with 
receptors, including soluble receptors (Akira & Takeda, 2004; Albee & Perlman, 
2006; Allan, Tyrrell & Rothwell, 2005; de Groot et al., 2005).  
 
Cytokines are involved in diverse actions, including antigen presentation, 
control of immune effectors and inflammation, lymphocyte proliferation and   15 
differentiation, cellular recruitment and activation, and adhesion molecule 
expression. Some cytokines have behavioural, endocrinological and metabolic 
effects (Borish & Steinke, 2003; Hanada & Yoshimura, 2002; Mackay, 2001). 
Cytokines such as IL-1β, IL-6, IL-8, TNF-α, IL-10 and transforming growth 
factor-beta 1 (TGF-β1) have been proposed to play a physiological role at 
parturition by being involved in the regulation of parturition (Bowen et al., 2002; 
Keelan et al., 2003). Furthermore, cytokines appear to be an important component 
of a paracrine/autocrine communication network in the mammary gland at the 
different stages of pregnancy and parturition (Hennighausen & Robinson, 2005; 
Ip, Shoemaker & Darcy, 1992; Rainard & Riollet, 2006; Varela & Ip, 1996). It 
should be noted that some baseline production of some of these cytokines may 
take place in clinically healthy individuals (Hagiwara et al., 2000; Hebisch et al., 
2004; Vangroenweghe, Lamote & Burvenich, 2005).  
 
The proinflammatory cytokines 
The proinflammatory cytokines mediate the early inflammatory response to 
microbial challenges and play a dual pathophysiological role, which may either 
promote or limit the processes of inflammation by activating other cells to release 
anti-inflammatory mediators (Akira, Taga & Kishimoto, 1993; Kodama, Davis & 
Faustman, 2005; Kofler, Nickel & Weis, 2005; Svanborg, Godaly & Hedlund, 
1999; Tracey, 2002). This in turn makes them associate with symptoms of disease 
(Allan, Tyrrell & Rothwell, 2005; Barber & Yang, 1998; Beutler & Rietschel, 
2003; Borish & Steinke, 2003; Fossum et al., 1998; Hirano, 1998). The systemic 
effects include the induction of hepatic synthesis and secretion of APPs, and 
changes in body temperature, blood flow and blood pressure through activation of 
the immune system (Baumann & Gauldie, 1994; Riollet, Rainard & Poutrel, 
2000a). One of these symptoms is elevation of the body temperature, which is 
mainly caused by IL-1β, IL-6 and TNF-α (Conti et al., 2004; Dinarello, 2004; 
Romanovsky et al., 2005).  
 
In addition to their role in the systemic symptoms of disease, the 
proinflammatory cytokines are considered to initiate the inflammatory response to 
microbial invasion, contributing to the establishment of inflammation by altering 
vascular permeability, and promoting the accumulation of leukocytes and certain 
soluble factors at the site of infection (Baumann & Gauldie, 1994; Riollet, Rainard 
& Poutrel, 2000a).  
 
Interleukin-1 is known to influence thymocyte proliferation and B cell growth 
and differentiation and is necessary to stimulate the production of IL-2, IL-6 and 
chemokine attractants for neutrophils such as macrophage inflammatory protein-2 
(MIP2) and IL-8 (Armstrong et al., 2004). Interleukin-1, which is produced during 
infection, not only has local effects involving the local inflammatory response; it 
also has systemic effects including the induction of acute-phase responses and 
effects on appetite, sleep and body temperature (Allan, Tyrrell & Rothwell, 2005; 
Dinarello, 1996). 
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In vitro and in vivo studies in several species have clearly shown that the 
production of proinflammatory cytokines including IL-1β, IL-6, IL-8 and TNF-α 
is upregulated following challenge with E. coli or endotoxin derived from E. coli 
(Bannerman et al., 2003; Burvenich et al., 2003; Dosogne et al., 2002; 
McClenahan, Sotos & Czuprynski, 2005; Riollet, Rainard & Poutrel, 2000b; 
Shuster, Kehrli & Stevens, 1993; Vangroenweghe, Duchateau & Burvenich, 
2004). Previous studies on mastitis in cattle have shown positive correlations 
between the concentrations of IL-6 and TNF-α in blood and the severity of 
mastitis (Hagiwara et al., 2001; Nakajima et al., 1997; Sordillo & Peel, 1992).  
 
The anti-inflammatory cytokines 
To avoid detrimental inflammatory reactions, a balance between activation and 
inhibition is needed throughout the immune response. Therefore, anti-
inflammatory mediators such as IL-10 and TGF-β1 are also released to inhibit the 
further release of proinflammatory mediators, limit the acute inflammatory 
response and prevent the spread of inflammatory mediators into the bloodstream 
(Finlay & McFadden, 2006; Navarre & Zychlinsky, 2000; Portnoy, 2005; Tracey, 
2002). In humans, the production of IL-10 and TGF-β1 have been found in normal 
mammary tissues and breast milk (Garofalo et al., 1995; Gomm et al., 1991; 
Rigotti et al., 2006; Saito et al., 1993). Interleukin-10 prevents the development of 
immunopathological lesions that result from an exacerbated protective immune 
response to acute and chronic infections. Overexpression of IL-10 correlates with 
diminished host cell activity and the failure to control bacterial infections (Mege et 
al., 2006; Moore et al., 2001). Transforming growth factor-beta can modulate 
expression of adhesion molecules, provide a chemotactic gradient for leukocytes 
and other cells participating in an inflammatory response, and inhibit them once 
they have become activated (Letterio & Roberts, 1998). It has been reported that 
TGF-β not only suppresses the generation of T helper type 1 (TH1) and TH2 cells 
(Taylor et al., 2006), but also is directly involved in the generation of TH17 cells 
that produce IL-17, which in turn promotes a range of immune-mediated 
inflammatory diseases (Cua & Kastelein, 2006). Studies in cattle have shown that 
the production of IL-10 (Bannerman et al., 2004), TGF-β1 and TGF-β2 
(Chockalingam, Paape & Bannerman, 2005) in milk increases following 
intramammary inoculation with E. coli. 
 
Hormones and acute-phase proteins 
The activation of the hypothalamic-pituitary-adrenal (HPA) axis is achieved prior 
to parturition, leading to increased production of cortisol and prostaglandins 
(PGs). Production of PGs is stimulated by cortisol. Prostaglandins play a 
physiological role at parturition by being involved in the drive towards contractile 
activity and parturition (Britt, Almond & Flowers, 1999; Challis, Lye & Gibb, 
1997; Mitchell et al., 1995). However, both cortisol and PGs have immune 
modulatory effects. Around parturition, high cortisol concentrations in blood may 
be largely responsible for delaying neutrophil recruitment and activation (Burton 
& Erskine, 2003). In the sow, it is well established that the concentrations of these 
hormones vary around parturition with peak plasma concentrations of cortisol up   17 
to approximately two to three times (Baldwin & Stabenfeldt, 1975; Österlundh, 
Holst & Magnusson, 1998). In addition to their physiological role at parturition, 
cortisol and the PGs are also involved in the inflammatory response to invading 
bacteria. In pigs, it has been reported that the concentrations of cortisol and 
prostaglandin F2-alpha (PGF2α) in blood increased following experimental 
administration of Salmonella typhimurium endotoxin (Garcia et al., 1998; 
Magnusson et al., 1994). Further, increased plasma concentrations of 
prostaglandin E (PGF2α) (Mwanza et al., 2001) and PGE2 (Wright et al., 2000) 
have been found after administration of LPS derived from E. coli.   
 
The APPs are a group of serum proteins that undergo substantial quantitative 
changes in response to infection or trauma (Baumann & Gauldie, 1994; Heinrich, 
Castell & Andus, 1990). Hepatocytes increase their synthesis and secretion of 
APPs, including SAA, Hp, C-reactive protein (CRP) and fibrinogen when 
stimulated by IL-1, IL-6 and TNF-α (Baumann & Gauldie, 1994; Suffredini et al., 
1999; Taga & Kishimoto, 1997). An inflammatory response can therefore be 
readily monitored by quantifying the concentration of these serum proteins which 
are produced in significant amounts by the liver in response to the 
proinflammatory cytokines. Serum concentrations of individual APPs may 
increase from two to three times to several hundred times during the acute phase 
of an inflammation. In addition to hepatocyte synthesis and secretion of Hp and 
SAA, extrahepatic synthesis of these proteins in the bovine mammary gland has 
also been reported (Hiss et al., 2004; McDonald et al., 2001). In pigs the 
concentrations of Hp and SAA in blood increased following experimental 
infection with Actinobacillus pleuropneumoniae (A. pleuropneumoniae) (Hall et 
al., 1992; Heegaard et al., 1998), or Mycoplasma hyorhinis (Magnusson et al., 
1999). As regards mastitis, concentrations of Hp and SAA in blood have been 
reported to have increased in dairy cows with naturally occurring mastitis (Conner 
et al., 1986; Eckersall et al., 2001) or in cows with experimentally induced E. coli 
mastitis (Salonen et al., 1996), but when the present study was initiated the role of 
soluble mediators of the early inflammatory response in the mammary gland of the 
sow was largely unknown. 
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Aims of the study 
The overall objective of the present work was to monitor the induction of some 
key factors involved in the early inflammatory response in the mammary gland of 
periparturient sows to experimentally induced E. coli mastitis. We wanted to gain 
a better understanding of why some sows develop clinical mastitis when 
challenged with environmental E. coli, while others remain clinically healthy. 
 
The specific aims were to − 
•  establish a technology that enables the detection and quantification of 
selected cytokines and cellular receptors in biopsy material from porcine 
mammary glands;  
  
•  test the hypotheses that concentrations of the proinflammatory cytokines 
TNF-α and IL-6, and the acute-phase proteins SAA and haptoglobin in 
blood increase in sows following intramammary E. coli inoculation, and 
that sows that develop clinical signs of mastitis have higher 
concentrations of TNF-α, IL-6, SAA and Hp in blood than do sows that 
remain clinically healthy; 
 
•  investigate whether there is a constitutive as well as an induced 
proinflammatory cytokine mRNA expression and protein production in 
mammary glands of sows intramammarily inoculated with E. coli at 
parturition;  
 
•  establish whether regulatory cytokine production varies between 
mammary glands of sows that do and sows that do not develop clinical 
signs of mastitis;  
 
•  evaluate whether mRNA expression of IL-1R1, TLR2 and TLR4 is 
upregulated in the mammary gland of sows following intramammary E. 
coli inoculation, and whether this expression differs between sows that 
develop clinical signs of mastitis and sows that remain clinically healthy; 
and   
 
•  investigate whether there is consistency in the variations in cytokine 
levels between different physiological compartments in sows 
intramammarily inoculated with E. coli. 
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Methodological considerations 
Experimental design and sample collection 
The samples analysed in the present study (and summarized in Table 1) originate 
from previous studies performed by Österlundh et al. (2002) and Löving & 
Magnusson (2002) on a total of 16 crossbred (Swedish Landrace × Yorkshire) 
primiparous sows. The animals were obtained from a commercial farm 
approximately 6−8 weeks before farrowing and used in the present study, 16 sows 
for Paper I, and twelve inoculated sows for Papers II−IV. Prior to the start of the 
trial, clinical signs of mastitis or other diseases were not observed in any of the 
sows. Experimental procedures and housing conditions were approved by the 
Ethical Committee for Animal Experiments, Uppsala, Sweden. 
 
   
 
                                   Inoculation        
                                                                     Affected (n = 4) 
 
                                                         Remained clinically healthy (n = 8) 
                                                                                                                                                                                           
-11 ~ -3  -2  -1  1  2  3  4 
                     Days prepartum                                         Days postpartum                                                 
                                                
                                               
                                                    Non-inoculated (n = 4) (only Paper I) 
 
 
 
 Figure 1. Schematic description of the experimental design.  
 
Experimental model and inoculation 
The experimental model and categorization of sows have previously been 
described in detail (Österlundh et al., 2002). In brief, the sows were randomly 
assigned to two groups. Sows in the non-inoculated group (n = 4) (Paper I) 
underwent normal farrowing, while sows in the inoculated group (n = 12) (Papers 
I−IV) were inoculated with E. coli (serotype O127) (Pedersen Mörner, Faris & 
Krovacek, 1998). Each teat at the right side of the mammary glands (i.e. of 
inoculated mammary glands) was inoculated with 0.5 mL of bacterial suspension 
(10
5 colony-forming units (CFUs)/mL) during the 24-hour period preceding 
parturition (Fig. 1). The concentrations of bacteria in culture solution were 
confirmed retrospectively using the viable count method (Söderlind, 1973). The 
contralateral mammary glands were used for sampling from non-inoculated 
mammary glands.  
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Table 1. Overview of samples used and analyses performed in the present study 
 
Sows  
Inoculated sows 
Samples and analyses 
Affected (n = 4)  Non-affected (n = 8) 
Non-
inoculated 
sows (n = 4) 
Serum/plasma  
ELISA 
IL-6, TNF-α, SAA, Hp, cortisol 
Mammary gland biopsies  Inoculated Non-inoculated 
IHC  
RT-PCR 
qRT-PCR 
 
IL-1β, IL-6, IL-8, TNF-α 
IL-1β, IL-6, IL-8, TNF-α 
IL-1β, IL-6, TNF-α, IL-10, TGF-β1,  
IL-1R1, TLR2, TLR4  
Not analysed 
 
For an explanation of the abbreviations used, see “Abbreviations”. 
 
Clinical examination and categorization of animals 
During the experiment, clinical examinations were performed within 48 hours 
postpartum, including palpation of the mammary glands, and recording of rectal 
temperature, habitus and appetite as described (Österlundh et al., 2002). Sows that 
exhibited all the symptoms of clinical mastitis, i.e. fever of > 39.5°C, anorexia, 
lethargy, and swelling of two or more mammary glands, were categorized as 
affected. Based on this, four of the inoculated sows were categorized as clinically 
affected. The other eight animals were categorized as non-affected, some had mild 
habitus and affection of the appetite or a fever on one or two measurement 
occasions, and one sow had mild mammary swelling. 
 
Blood samples (Paper I) 
Blood samples were collected from non-inoculated and inoculated sows for 3 
consecutive days within 3−11 days prepartum, and 0, 24, 48, 72 and 96 hours after 
inoculation, respectively (Fig. 1). Plasma and serum samples were collected and 
stored at -80°C until subsequent analysis. 
 
Biopsy samples (Papers II−IV)  
The biopsy procedure was performed as previously described (Magnusson, 1999), 
with some modifications (Löving & Magnusson, 2002). Briefly, two biopsies per 
mammary gland were carried out using a human Bard
® Magnum
® Biopsies 
instrument and a Core Tissue Biopsy Needle (12 G × 10 cm) (CR BARD Inc., 
Covington, GA, USA). Mammary gland biopsy was performed immediately 
before inoculation and from the inoculated and the contralateral non-inoculated 
mammary glands, 24 hours after inoculation. The samples were designated as the 
pre-inoculation, non-inoculated and inoculated samples, respectively. On each 
sampling occasion, mammary glands were used that had not been sampled 
previously. The specimens were immediately frozen in liquid nitrogen and stored 
at -80°C until used for analyses. 
 
   21 
Blood analyses (Paper I) 
Plasma IL-6, serum TNF-α and plasma SAA concentrations were assayed (Plasma 
IL-6, using polyclonal anti-porcine IL-6 antibody; serum TNF-α, using 
monoclonal anti-porcine TNF-α antibody (R & D Systems Europe Ltd, Abingdon, 
UK); and plasma SAA, using monoclonal antibody specific for SAA (Tridelta 
Development Ltd, Bray, Wicklow, Ireland)) by means of commercially available 
enzyme-linked immunosorbent assay (ELISA) kits according to the 
manufacturers’ instructions.  
 
Serum Hp concentrations were determined using an automated chemistry 
analyser (Cobas Mira; Hoffman-La Roche Ltd, Basel, Switzerland) for a 
haemoglobin-binding method (Phase Range haptoglobin assay reagent kit; Tridelta 
Development Ltd, Bray, Wicklow, Ireland). 
 
Plasma cortisol concentrations were determined by means of a solid-phase   
radioimmunoassay kit (Coat-A-Count Cortisol; Diagnostic Products Corporation, 
Los Angeles, CA, USA) validated for use in porcine plasma (Österlundh, Holst & 
Magnusson, 1998). 
 
Reverse transcriptase-polymerase chain reaction and nested 
polymerase chain reaction (Paper II) 
The extraction of total RNA from tissues with low concentrations of mRNA is the 
key step in reverse transcriptase-polymerase chain reaction (RT-PCR) from 
limited tissue samples (e.g. biopsies). The combined use of two commercially 
available RNA isolation kits that consistently produce high-quality RNA was 
therefore applied (Papers II and IV). Briefly, total RNA was extracted from frozen 
mammary biopsy samples using TRIzol Reagent (Invitrogen Ltd, Paisley, UK), 
followed by additional RNeasy Spin Column purification. The resuspended RNA 
was further purified through the RNeasy Isolation System (Qiagen Ltd, Crawley, 
UK) using RNeasy Spin Columns. For each sample, the amount of RNA extracted 
was determined and its purity (OD260/OD280 absorption ratio > 1.90) verified 
before storage at -80°C.  
 
An amount of 2 μg of total RNA was reverse-transcribed to synthesize first- 
strand complementary deoxyribonucleic acid (cDNA) using reverse transcriptase 
(Invitrogen Ltd, Scotland, UK). Several reverse transcription reactions of each 
sample were run and pooled at the end in order to minimize the differential 
synthesis of cDNA in each reaction. The cDNAs were then used as templates for 
PCR. The products from PCR reactions were used as templates in separate nested 
PCR reactions. Repeated experiments were carried out in order to determine the 
optimal cycle number for each cytokine to ensure that the analyses were 
performed at the exponential phase of amplification, before the saturation level 
was reached. The PCR products were separated by agarose gel electrophoresis. 
After staining with ethidium bromide, the band intensities of the PCR products 
were measured by a ChemiDoc Imager (Bio-Rad Laboratories, Inc, CA, USA).   22
The intensity of the bands was quantified by densitometry analysis using Quantity 
One software (Bio-Rad Laboratories, Inc, CA, USA). Cytokine mRNA expression 
was presented as the ratio of the cytokine band intensity in relation to the 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) band 
intensity.  
 
Before the real-time RT-PCR technique was developed, standard RT-PCR was 
used as a semi-quantitative assessment of gene expression. However that method 
is undoubtedly less sensitive compared with quantitative real-time RT-PCR, while 
conventional quantification protocols are labour-intensive, time-consuming and 
highly expensive. Consequently, standard RT-PCR is mainly applicable to 
determining the expression or absence of expression of mRNA for a certain gene.  
 
Real-time reverse transcriptase-polymerase chain reaction 
(Paper IV) 
Quantitative real-time RT-PCR (qRT-PCR) has been recognized as an accurate 
and sensitive method for the detection and quantification of gene expression 
levels, in particular for low abundance mRNA, in tissues with low concentrations 
of mRNA. Because real-time RT-PCR can be monitored directly during the PCR 
process using fluorogenic probes, it offers the opportunity to observe the 
amplification kinetics of a PCR in “real time” via accumulation and measurement 
of specific fluorescence signals with each cycle (Bustin, 2000; Heid et al., 1996). 
Fluorescently labelled probes provide a highly sensitive and specific method of 
detection, since only the desired PCR product is detected.  
 
The purity and the integrity of RNA are critical elements for the overall success 
of RNA-based analyses. The integrity of total RNA was analysed by use of the 
Agilent RNA 6000 Nano Kit, and the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Waldbronn, Germany). In addition, some RNA aliquots were 
treated with deoxyribonuclease I (DNaseI) to eliminate genomic DNA (gDNA), 
which can influence the interpretation of real-time RT-PCR assay data. The RT-
PCR amplification was conducted using the Rotor-Gene™3000 (Corbett Robotics 
Pty Ltd, Brisbane, Australia). One hundred nanogram of total RNA were added 
directly to a TaqMan one-step RT-PCR reaction containing rTth DNA polymerase 
enzyme (Applied Biosystems, Stockholm, Sweden). A no template control of 
nuclease-free water was included in each run. All reactions were performed in 
duplicate. In Paper IV, most of the cytokine and receptor real-time RT-PCR assays 
were adopted from published methods. However, each system was re-evaluated 
and optimized for the current approach. All reagents were titrated for optimal 
performance using total RNA isolated from porcine peripheral blood mononuclear 
cells (PBMCs) that were induced to produce the various cytokines and receptors 
according to established protocols (Andersson et al., 2007).  
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Figure 2. Serial dilutions of total RNA extracted from mammary biopsy samples were 
amplified by real-time RT-PCR using gene-specific primers to calculate the amplification 
efficiency (E) of each system (i.e. direct the Rotor-Gene software output). (a) Amplification 
plot for the target gene porcine Toll-like receptor, TLR4, showing 40 cycles of 
amplification of five dilutions (triplicate) of a fivefold dilution series of template RNA, and 
two no-template controls. The threshold is shown by the purple line. (b) The derived 
standard curve (a plot of CT v log of concentration) from the amplification plot. The E of 
porcine TLR4 was determined using the CT slope method with five data points 
(concentrations).  
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One of the major concerns regarding any real-time RT-PCR assay is the 
amplification efficiency (E). The E-value is empirically determined from the 
amplification of serial dilutions of the template RNA according to the following 
equation:  
 
E = [10
(-1/slope)] -1,  
 
where the slope is calculated from the standard curve of total RNA concentrations 
v the CT values (i.e. the fractional cycle number at which the fluorescence exceeds 
a fixed threshold) (Bustin & Nolan, 2004). In Paper IV, fivefold serial dilutions 
(triplicate) of total RNA extracted from mammary biopsy samples were amplified 
by real-time RT-PCR using gene-specific primers (e.g. Fig. 2a) to calculate the E 
of each system. The determined E-values were 0.99 for TLR4 (Fig. 2b), 1.02 for 
hypoxanthine phosphoribosyl-transferase (HPRT), 0.99 for TLR2, 1.06 for IL-1β, 
and 0.90 for IL-1R1, most of them close to the theoretical efficiency of E = 1.0, 
but the determined E-value for IL-6 was 0.72.  
 
The use of an endogenous reference gene corrects for variation in RNA content, 
variation in reverse-transcription efficiency, possible RNA degradation or 
presence of inhibitors in the RNA sample, variation in nucleic acid recovery, and 
differences in sample handling. The expression level of the endogenous reference 
gene should not vary under different experimental conditions or in different states 
of the tissue; however, an ideal candidate gene which remains unchanged in each 
situation is not available (Bustin, 2002; Giulietti et al., 2001). It should be noted 
that different reference genes are suitable for different organs. The most common 
housekeeping genes used in the relative expression studies of immunologically 
relevant genes in the pig are β-actin, cyclophilin, GAPDH and HPRT (Andersson 
et al., 2007; Ledger et al., 2004). The housekeeping genes GAPDH (Duvigneau et 
al., 2005) and HPRT (Foss, Baarsch & Murtaugh, 1998) are considered to be 
acceptable as the endogenous reference genes when comparing different porcine 
tissues and immune cells. In Paper IV the CT value was determined for each 
sample. To evaluate the relative mRNA expression, samples were normalized to 
the housekeeping gene HPRT. However, it has been suggested that the geometric 
mean of multiple carefully selected reference genes can be used for normalization 
(Duvigneau et al., 2005; Skovgaard et al., 2007).  
 
Immunohistochemistry and image analysis (Paper III) 
The analyses of biopsies collected from mammary glands of sows inoculated with 
E. coli demonstrated the transcription of the genes for a number of 
proinflammatory cytokines, but the analyses of IL-6 and TNF-α in the same set of 
sows revealed that variations in concentrations in blood are not reflected in the 
mRNA expression in mammary tissues (Papers I and II). This observation 
indicates the need to relate observations at the mRNA level to the protein level in 
order to understand the biological significance of the mRNA results and possibly 
disclose mechanisms of regulation. A semi-quantitative assessment of the amount   25 
of cytokine in the mammary gland was therefore established using 
immunohistochemistry (IHC) analysis combined with image analysis (Paper III). 
 
Pilot studies in our laboratory have shown that the cytokines are located both in 
the cytoplasmic compartments and scattered throughout the cells in mammary 
tissues. For such distribution of immunoreactive proteins, computerized image 
analysis is far more reproducible than manual scoring in assessing positive areas 
(Elsasser et al., 2004; Huse et al., 2006). Even so, IHC is only a semi-quantitative 
assessment of the amount of cytokine, and gives a relative measurement implying 
that quantitative comparisons between the various cytokines are not possible. 
  
The 3, 3’-diaminobenzidine tetrahydrochloride (DAB)-stained areas, i.e. the 
positively stained areas, in the sections (counterstained with 10% Mayer’s 
haematoxylin and mounted with glycerolgelatin) were quantified using Easy 
Image 3000 (Tekno Optik AB, Göteborg, Sweden). Five fields (magnification, 
200 ×) from each tissue sample (three section slices were mounted per slide) were 
captured using a Nikon Microphot FXA equipped with a Nikon DS-5M digital 
camera (Nikon, Tokyo, Japan). The DAB colour-specific staining was determined 
by defining a threshold for hues and intensities that corresponded to those colour 
attributes that were assessed as positive in five randomly selected samples within 
the same assay run, compared with negative controls. This spectral threshold was 
then used for analysing all images for that particular cytokine within the same IHC 
run. In this way, unbiased continuity of analysis across samples was achieved. For 
each sample, a relative value of the amount of cytokine produced was expressed as 
the average percentage of the positively stained areas in five view fields. These 
data were accordingly considered semi-quantitative. 
 
Statistical analysis  
Statistical evaluation was performed using the SAS statistical software package, 
Version 9.1 (SAS Institute Inc., Cary, NC, USA).  
 
Data from blood samples (Paper I) were analysed using analysis of variance 
(ANOVA) for repeated measures. The statistical model included the fixed effect of 
sow category, time of sample collection, and the interaction between sow category 
and time of sample collection. To account for repeated measures, the statistical 
model also included the random effect of sow within sow category. When there 
was an overall significant effect of sow category or time of sample collection, 
differences between means were compared using Student’s t-test.  
 
Data from mammary tissue samples (Papers II−IV) were analysed using PROC 
MIXED. The statistical model included the fixed effect of sow category, the 
mammary gland sample and the interaction between sow category and mammary 
gland sample, and the random effect of sow within sow category. When there was 
an overall effect of sow category or mammary gland sample (p < 0.05), pairwise 
comparisons between the least-square means were made. P-values < 0.05 were 
considered statistically significant.   26
Results and Discussion 
More knowledge about the inflammatory response and its regulation following 
bacterial-induced mastitis is needed to gain a better understanding of why certain 
sows develop clinical signs of mastitis when challenged with environmental 
bacteria, and others remain clinically healthy. In the current experiment only one- 
third of the inoculated sows developed clinical mastitis. Previous studies using the 
same experimental model but focusing on granulocytes that are crucial for 
bacterial clearance in the mammary gland, did not indicate any impaired function 
of these cells before inoculation, in the sows that developed clinical signs of 
mastitis (Österlundh et al., 2002). The present study of the innate immune system 
in periparturient sows, responding to experimentally induced E. coli mastitis, 
therefore concentrated on the events preceding the granulocyte response. In 
particular, soluble factors that may be involved in the early inflammatory response 
were explored.  
 
The proinflammatory cytokines and the acute-phase proteins as 
markers for mastitis 
The proinflammatory cytokines in blood – markers for coliform mastitis 
Increased concentrations of IL-6 and TNF-α in blood were found following 
intramammary E. coli inoculation. Furthermore, the concentrations of IL-6 and 
TNF-α in blood were significantly higher in sows that developed clinical signs of 
mastitis than in sows that remained clinically healthy 24 hours after inoculation 
(Paper I). These data are consistent with previous studies in cattle, in which the 
levels of IL-6 and TNF-α in blood correlated with the severity of coliform mastitis 
(Nakajima et al., 1997; Sordillo & Peel, 1992). 
 
The presence of cytokines in blood collected from healthy, pregnant sows 
(Paper I) is in accordance with findings in pregnant women (Hebisch et al., 2004; 
Vassiliadis et al., 1998), and appears to be important at different stages of 
pregnancy and parturition (Alvarez-de-la-Rosa et al., 2000; Denison, Kelly & 
Calder, 1997). Cytokines such as IL-1β, IL-6, IL-8, TNF-α, IL-10 and TGF-β 
have also been proposed to play a physiological role at parturition by being 
involved in the regulation of the parturition process as such (Bowen et al., 2002; 
Keelan et al., 2003).  
 
It seems that the production and the effect of some of the cytokines that are 
involved in the regulation of parturition are not reflected in blood, as revealed by 
the unaffected levels of IL-6, TNF-α (Paper I), IL-1β and IL-8 (Cicarelli et al., 
2005) during parturition. We showed a constitutive production of proinflammatory 
cytokines in blood collected from healthy, pregnant sows, while no increase in the 
concentrations of IL-6 and TNF-α in blood was found following the onset of 
parturition. These results are in accordance with a previous study in humans, in 
which the concentrations of IL-1β and TNF-α in blood were unaltered during all 
the periods of collection (Cicarelli et al., 2005). By contrast, in another study,   27 
increased serum concentrations of IL-1β and IL-6 were found at normal term 
delivery (Hebisch et al., 2004).  
 
Obviously, there are contradictions in the literature about the increase in 
proinflammatory cytokines in blood at normal parturition. It should be mentioned 
that the frequency of sample collection and the definition of “peripartum” may 
influence the results. In the present study, we established strict time points to 
define peripartum. Our data indicate that the concentrations of IL-6 and TNF-α in 
porcine blood are not affected by normal parturition. Taken together, these 
findings suggest that IL-6 and/or TNF-α in blood could be used as markers for 
identification of periparturient sows with coliform mastitis.   
 
The acute-phase proteins and cortisol 
Previous studies in cattle have suggested that the concentrations of Hp and SAA in 
blood may have the potential to be used in detection of the disease, but they could 
not be used for discriminating the severity of mastitis (Eckersall et al., 2001; 
Lehtolainen, Rontved & Pyörälä, 2004). Here we found that the levels of Hp and 
SAA in blood increase 24 and 48 hours after normal parturition, respectively 
(Paper I). This is why we did not observe a specific increase in serum Hp 
concentrations following inoculation with E. coli. Our data revealed that plasma 
SAA concentrations increased 24 hours after intramammary E. coli inoculation, 
but we were unable to observe any difference in the levels of SAA and Hp in 
blood between sows that developed clinical signs of mastitis and sows that 
remained clinically healthy after inoculation. Although we found increased plasma 
cortisol concentrations in sows that developed clinical signs of mastitis 24 hours 
after inoculation, the present (Paper I) and previous studies in pigs showed that the 
levels of cortisol in blood also increase around normal parturition (Baldwin & 
Stabenfeldt, 1975; Magnusson et al., 2001; Österlundh, Holst & Magnusson, 
1998). These observations suggest that plasma SAA, serum Hp and plasma 
cortisol are less suitable as markers for coliform mastitis in periparturient sows. 
 
Cytokine responses in the mammary gland to intramammary 
Escherichia coli inoculation   
Cytokine production in normal mammary glands  
Cytokines appear to be an important component of a paracrine/autocrine 
communication network in the mammary gland at different stages of pregnancy 
and parturition (Hennighausen & Robinson, 2005; Rainard & Riollet, 2006). 
Cytokine production at both the mRNA (Papers II and IV) and the protein (Paper 
III) level was seen in normal mammary glands of pregnant sows. Our findings are 
consistent with previous studies in humans (Adams, Rafferty & White, 1991; 
Basolo et al., 1993; Garofalo et al., 1995; Gomm et al., 1991; Green et al., 1997; 
Palkowetz et al., 1994) as well as in cattle (Hagiwara et al., 2000; McClenahan et 
al., 2006; Okada et al., 1997) in which some baseline production of cytokines 
takes place in normal mammary glands. Indeed, our data demonstrate that 
cytokines can be produced and secreted in the mammary gland.    28
The pre-inoculation production of IL-6 in blood was lower in sows that 
developed clinical signs of mastitis compared with sows that remained clinically 
healthy (Paper I). By contrast, when studying mammary glands in the same set of 
sows, no differences were found between the two groups in their pre-inoculation 
levels of IL-6 measured by RT-PCR (Paper II) and qRT-PCR (Paper IV), or 
determined by IHC analysis (Paper III). Possible explanations for this 
inconsistency between systemic and local proinflammatory cytokine levels may be 
that the proinflammatory cytokines could also be produced elsewhere (Baumann 
& Gauldie, 1994; Kofler, Nickel & Weis, 2005).  
 
Notably, the pre-inoculation levels of IL-1β (Papers II−IV) were lower in the 
mammary glands of sows that developed clinical signs of mastitis compared with 
sows that remained clinically healthy. The underlying mechanisms of this remain 
unknown, although it has been reported that IL-1 is necessary to stimulate the 
production of chemokine attractants for neutrophils such as MIP2 and IL-8, which 
in turn recruit neutrophils to the site of infection, an event required for bacterial 
clearance (Armstrong et al., 2004; Gamero & Oppenheim, 2006; Miller et al., 
2006). Consequently, these earlier data and the data presented here call for further 
studies to elucidate a possible role of IL-1β in protection against coliform mastitis. 
 
Proinflammatory cytokine responses in the mammary gland  
The analyses of proinflammatory cytokines by standard RT-PCR (Paper II) and 
qRT-PCR assays (Paper IV), as well as IHC analysis (Paper III) indicated an 
increased production of IL-1β, IL-6 and TNF-α in the inoculated mammary glands 
of sows that developed clinical signs of mastitis. By contrast, in sows that 
remained clinically healthy there was no increase in the production of IL-1β, IL-6 
(Papers II and III), and TNF-α (Paper III) in the inoculated mammary glands. 
However, as shown by qRT-PCR assays (Paper IV), there was an increase in the 
expression of IL-1β and TNF-α mRNAs also in these sows. Moreover, IL-1β 
mRNA expression was higher in the inoculated mammary glands of sows that 
developed clinical signs of mastitis compared with those that remained clinically 
healthy following intramammary inoculation. The discrepancy between the two 
studies is likely due to the fact that qRT-PCR assays are more sensitive and have a 
much greater range when comparing different levels of nucleic acid, compared 
with standard RT-PCR assays. 
 
In accordance with our results, previous studies in cattle have shown a 
significant increase in the proinflammatory cytokines IL-1β, IL-6, IL-8, and TNF-
α at the level of both mRNA (Lee et al., 2006; McClenahan et al., 2006) and 
protein (Bannerman et al., 2004; Blum et al., 2000; Chockalingam, Paape & 
Bannerman, 2005; Hoeben et al., 2000; Lee et al., 2003; Riollet, Rainard & 
Poutrel, 2000b; Shuster et al., 1997; Vangroenweghe, Duchateau & Burvenich, 
2004) in either mammary tissues or milk collected from infected glands following 
intramammary inoculation with E. coli. These data indicate that development of 
clinical symptoms of coliform mastitis is associated with locally increased 
proinflammatory cytokine production in response to intramammary E. coli 
inoculation.     29 
Interleukin-1, which is produced during infection not only has local effects, 
involving the local inflammatory response, but also has systemic effects, including 
the induction of acute-phase responses and effects on appetite, sleep and body 
temperature (Allan, Tyrrell & Rothwell, 2005; Dinarello, 1996). Most of the   
biological actions of IL-1 seem to be mediated through specific receptors 
including IL-1R1 (Dinarello, 1996). It was somewhat unexpected that no increase 
in IL-1R1 mRNA expression was found in mammary glands in any of the groups 
(Paper IV). Interestingly, some studies have indicated that the effects of IL-1β are 
not only mediated by IL-1R1 (Parker et al., 2002; Touzani et al., 2002). Whether 
this could be the case in the mammary gland is currently unknown. 
 
As regards IL-8, an increased production at both the mRNA (Paper II) and the  
protein (Paper III) level was found in the inoculated mammary glands of both 
sows that did and sows that did not develop clinical signs of mastitis. Likewise, an 
increase in IL-8 mRNA expression (Paper II) was found in the non-inoculated 
mammary glands in both groups of sows after inoculation. This may suggest that 
in the lactating porcine mammary gland, IL-8 has a physiological role to attract 
neutrophils. This is supported by data in other species and by data showing that 
colostrum collected from healthy sows contains a high proportion of neutrophils 
(Magnusson, Rodríguez-Martínez & Einarsson, 1991; Negus, 1996). This 
physiological increase in local production of IL-8, following the onset of 
parturition, may explain why we did not observe any difference in IL-8 production 
in mammary glands between sows that developed clinical signs of mastitis and 
sows that remained clinically healthy after inoculation (Paper III). By contrast, as 
shown by standard RT-PCR assays (Paper II), IL-8 mRNA expression was higher 
in the inoculated mammary glands of sows that developed clinical signs of mastitis 
than in those that remained clinically healthy. Similarly, a previous study in cows 
showed that the concentrations of IL-8 in milk in infected quarters were higher in 
cows that developed moderate clinical signs of mastitis than in those that 
developed mild clinical signs of mastitis following intramammary E. coli 
inoculation (Vangroenweghe, Duchateau & Burvenich, 2004).  
 
Anti-inflammatory cytokine responses in the mammary gland  
Anti-inflammatory cytokines such as TGF-β and IL-10 specifically inhibit the 
release of TNF and other proinflammatory mediators (Tracey, 2002; Tsunawaki et 
al., 1988). Interleukin-10 is regarded as a critical anti-inflammatory mediator, 
while overexpression of IL-10 correlates with diminished host cell activity and the 
failure to control bacterial infections (Mege et al., 2006; Moore et al., 2001). As 
shown by qRT-PCR assays, IL-10 mRNA expression increased in the inoculated 
mammary glands of sows that developed clinical signs of mastitis as well as of 
those that remained clinically healthy 24 hours after inoculation (Paper IV). This 
is in accordance with a previous study in cows, in which the increased production 
of IL-10 was seen in milk collected from infected quarters 24 hours after 
intramammary inoculation with E. coli (Bannerman et al., 2004). Moreover, we 
showed that IL-10 mRNA expression was higher in the inoculated mammary 
glands of sows that developed clinical signs of mastitis compared with sows that 
remained clinically healthy (Paper IV).    30
Concerning TGF-β1, a recent study has shown increased concentrations in milk 
collected from infected quarters of cows 32 hours after intramammary inoculation 
with E. coli (Chockalingam, Paape & Bannerman, 2005). By contrast, we did not 
observe any increase in TGF-β1 mRNA expression 24 hours after inoculation 
(Paper IV). It cannot be excluded, however, that an increase in TGF-β1 mRNA 
expression may have been detected later after inoculation. 
  
In general, these findings suggest that development of clinical symptoms of 
coliform mastitis is associated with the degree of local production of regulatory 
cytokines in response to intramammary E. coli inoculation. 
 
Toll-like receptors and Escherichia coli in the mammary gland  
As shown by qRT-PCR assays (Paper IV), both TLR4 and TLR2 mRNA 
expression increased in the inoculated as well as the non-inoculated mammary 
glands of sows that developed clinical signs of mastitis and of sows that remained 
clinically healthy. However, TLR2 mRNA expression was higher in the inoculated 
mammary glands than in the non-inoculated mammary glands of the sows that 
remained clinically healthy. For TLR4, our data are inconclusive when it comes to 
discussing effects of E. coli inoculation as well as effects of normal parturition. 
Increased TLR4 and TLR2 mRNA expression in the inoculated mammary glands 
has previously been shown in cows with mastitis caused by either S. aureus or E. 
coli (Goldammer et al., 2004). Toll-like receptor 2 recognizes LTA from Gram-
positive bacteria, as well as peptidoglycan and bacterial lipoproteins abundant in 
the cell wall of Gram-positive and Gram-negative bacteria. Signalling via TLRs 
may commonly lead to the early activation of NF-κB and the subsequent 
expression and release of several proinflammatory mediators, including IL-1β, IL-
6 and TNF-α (Aderem & Underhill, 1999; Akira & Takeda, 2004). Moreover, the 
increased expression in the non-inoculated mammary gland shown here (Paper IV) 
indicates a systemic release of factors that upregulate TLR2 expression, in 
addition to local induction at the site of infection. Even so, it may be that the 
expression of TLR2 as well as of TLR4 is normally upregulated in the mammary 
gland around parturition. This possibility warrants further studies on the 
expression and regulation of TLRs during pregnancy and parturition. 
 
The discrepancy between systemic and local cytokine responses  
The present results also suggest that the increased blood levels of IL-6 and TNF-α 
are accompanied at least in part by a local response that is likely to be important in 
the defence against mastitis. We showed here that the concentrations of IL-6 and 
TNF-α in blood were higher in the sows that developed clinical signs of mastitis 
compared with sows that remained clinically healthy 24 hours after intramammary 
inoculation with E. coli (Paper I). By contrast, biopsy samples from mammary 
glands suggested that the levels of IL-6 and TNF-α in inoculated mammary glands 
did not differ significantly between the two groups 24 h after inoculation, as 
shown by IHC analysis (Paper III) or by qRT-PCR assays (Paper IV). Possible 
explanations for this discrepancy between systemic and local proinflammatory   31 
cytokine levels may be that proinflammatory cytokines could also be produced 
elsewhere, not only at the site of bacterial inoculation (Akira, Uematsu & 
Takeuchi, 2006; Baumann & Gauldie, 1994; Cohen, 2002). Alternatively, there 
could be a larger diffusion of cytokines into the blood in the sows with clinical 
signs of mastitis, which may be attributable to the inflammatory damage of 
mammary glands. It seems, therefore, that the discrepancy between different read-
outs should be taken into account when relating cytokines to infectious diseases.  
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Conclusions 
In the present thesis, 
 
•  RT-PCR and qRT-PCR, as well as semi-quantitative IHC analysis 
combined with image analysis, were applied in the detection and 
quantification of selected cytokines and cellular receptors in biopsy 
material from porcine mammary glands. 
 
The data presented in this thesis indicate that −  
 
•  concentrations of the proinflammatory cytokines IL-6 and TNF-α, and 
the acute-phase protein SAA in blood increase in sows following 
intramammary  E. coli inoculation. Furthermore, sows that develop 
clinical signs of mastitis have higher concentrations of IL-6 and TNF-α 
in blood than do sows that remain clinically healthy. The 
proinflammatory cytokines IL-6 and/or TNF-α in blood could be used as 
markers for identification of periparturient sows with coliform mastitis. 
  
•  some baseline production of cytokines takes place in normal mammary 
glands of pregnant sows, and sows that develop clinical signs of mastitis 
have significantly lower baseline production of IL-1β than do sows that 
remain clinically healthy.  
 
•  development of clinical symptoms of coliform mastitis is associated with 
the degree of local production of regulatory cytokines in response to 
intramammary E. coli inoculation.  
 
•  mRNA expression of TLR2 is upregulated in the mammary gland of sows 
following intramammary E. coli inoculation.  
 
•  the discrepancy between different read-outs should be taken into account 
when relating cytokines to infectious diseases.   
 
Overall, the findings from the present thesis work suggest that development of 
clinical symptoms of coliform mastitis is associated with the degree of local 
production of regulatory cytokines.  
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